MA: Sodium nitroprusside does not alleviate the symptoms of schizophrenia vs. placebo (MD-PANSS total and BPRS= -18; −1.40 to 0.02). The sensitivity analysis excluding the heterogeneous study maintain the absence of benefit (BPRS: -0.30; −0.93 to 0.32) htt
RT @Rational_Psych: Negative meta-analysis for sodium nitroprusside in schizophrenia (6 studies, total n 174) @IvanKoychev @drjmstone htt…
RT @Rational_Psych: Negative meta-analysis for sodium nitroprusside in schizophrenia (6 studies, total n 174) @IvanKoychev @drjmstone htt…
Negative meta-analysis for sodium nitroprusside in schizophrenia (6 studies, total n 174) @IvanKoychev @drjmstone https://t.co/XOSMpupjgf